Yes. So and back to Q4, I would also mention again this impact of the 53rd week. So you need to think about, I mean, exiting 2021 at a revenue growth of about 6%, as I did mention, which is really putting about this one time, even the [Indiscernible] years, or so that we have to deal with an additional week. So seeing about more like 6%, including, of course of world but we don't say where we are, I would say at about three and a half. So we know that we need some acceleration that I would say otherwise, I think it was a pretty okay, run rate revenue wise in the fag end of 2021. On the SG&A yes, you're right. I mean, when you look at, no, we like to use incremental conversion rate, which is basically saying well, if we deliver $100 more of GP, how much we push to the bottom line. That has been challenging, I would say, up to Q3 of last year. We have started to show meaningful leverage in Q4, our so called ITR, incremental conversion rate was about 24%, 25%. We think we can do better, especially again in 2022. One of the reasons is basically, improvement in, I would say, our cost management, which is a little bit challenging in the recovery phase. The second thing is more on 2022, where we expect to benefit from this Q4 2021 action, the outcome would be savings starting in 2022 in excess of 10 million. And that combined with really focusing on productivity improvements, and efficiency in each business unit should continue to provide meaningful improvement in what we call leverage or incremental conversion rate as we move into 2022.